President Trump has nominated Heidi Overton, a current White House domestic policy advisor, to be the next commissioner of the Food and Drug Administration. The appointment comes after the departure of former commissioner Marty Makary earlier this year, creating a period of instability at the agency.
Overton has been a strong supporter of the president’s health agenda, including efforts to overhaul the childhood vaccine schedule, a position that has drawn criticism from medical experts. According to sources, Trump called Overton a “ROCKSTAR.” She currently serves as a deputy assistant to the president for domestic policy, focusing on health issues.
While the nomination has been met with support from some, it has also upset hardcore activists within the Make America Healthy Again movement, potentially threatening the coalition’s strength heading into the 2026 midterm elections. If confirmed by the Senate, Overton will oversee the safety and effectiveness of food, drugs, and medical devices. Trump has also pledged to use Overton’s leadership to speed up the approval of new treatments.
No right-leaning sources reported on this story beyond the Washington Examiner’s coverage of the MAHA movement’s reaction, leaving the full scope of right-leaning perspectives on the nomination unclear.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy